You have no items in your shopping cart.
.png)
Custom recombinant antibody production involves the generation of antibodies using recombinant DNA technology. This process typically begins with the identification of antibody-encoding genes from immunised animals or human donors. These genes are then cloned into expression vectors and transfected into host cells, such as mammalian cells or bacteria, to produce recombinant antibodies.
Advantages of Biorbyt's Recombinant Antibody Products
High specificity
Recombinant antibodies generated by Biorbyt exhibit high specificity due to the precise targeting of desired epitopes, minimising off-target effects.
Customisation
Biorbyt offers tailored antibody production services, allowing for customization of antibody characteristics such as specificity, affinity, and isotype to meet specific research requirements.
Scalability
Biorbyt's recombinant antibody production capabilities are scalable, allowing for the generation of antibodies in bulk quantities.
Reduced animal use
Recombinant antibody production techniques employed by Biorbyt often involve minimal or no animal use.
Expertise and Support
Providing comprehensive support throughout the antibody development process, from design to validation.
Service Process
Peptide
Lead Time: 10-16 weeks
Recombinant Protein
Lead Time: 12-16 weeks
Native Protein
Lead Time: 12-16 weeks
Process
- Select positive gene
- Recombinant antibody expression
- Protein A/G purification
- ELISA, WB validation
Deliverables
- QC report of antigen
- 100ug of purified recombinant antibody with QC report (Includes gene information, gene sequence, concentration, purity, endotoxin content)
- WB positive guarantee for antigen
- Other applications validation available upon request (IHC, IF, IP, FC)
Please reach out to us at [email protected] to discuss your request for . Our scientists are here to answer your questions and provide you with the information and expertise you need for your projects.